The Global Orthobiologics Market (2018-2023) - Increasing Patient Preference for Minimally Invasive Procedures - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 6, 2018--The “Global Orthobiologics Market - Segmented by Product, Disease, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.
The global orthobiologics market is projected to register a CAGR of about 5.4% during the forecast period, 2018-2023.
Increasing Patient Preference for Minimally Invasive ProceduresLately, orthobiologics have come to be known as one of the prominent treatment option for early osteoarthritis (OA) of the knee. The interests about orthobiologcs in the medical community and growing research in the field of regenerative medicine, coupled with promising clinical results from the use of orthobiologics are helping to make the clinical applications of this treatment more diverse every day.Biological therapy or cellular arthroplasty is evolving rapidly in the management of OA. Repair of damaged cartilage and biological restitution can be possible by the judicious use of autologous biological products. This will help the orthobiologics market to flourish during the forecast period.Key HighlightsHigh Cost Associated with Orthobiologics-Based Treatments to Hamper Growth North America to Maintain the Lead in the Global Market
Notable Market DevelopmentsA conference was comducted that focused on orthobiologics at the Orthobiologic Singularity event, orthopedic medicine from invasive to regenerative.Bioventus, a global leader in orthobiologic solutions, announced that the US FDA approval was granted for DUROLANE, a single-injection, hyaluronic acid.Companies FeaturedArthrex Inc.Depuy Synthes (a Subsidiary of Johnson & Johnson)Globus Medical Inc.Harvest Technologies Corporation (a Terumo Bct Company)K2M Group Holdings Inc.Medtronic PLCRTI Surgical Inc.Seaspine Holdings CorporationStryker CorporationZimmer Biomet Holdings Inc.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/nr4dkh/the_global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005407/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Orthopedic Devices
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/06/2018 06:58 AM/DISC: 09/06/2018 06:58 AM